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ABSTRACT
Medication non-adherence is one of the most costly and difficult problems in healthcare today.
In the United States alone, half of the 3.5 billion prescriptions dispensed are not taken as
prescribed, costing our healthcare system an estimated $100 billion. Ten percent of all
hospitalizations and 125,000 deaths each year are attributable directly to non-adherence to
medicines. Medication non-adherence is a complex, multi-faceted problem and potential ways to
increase adherence to medications traditionally have focused on the physician - patient
relationship. However, medication dispensing requires an additional interaction between the
pharmacy and patient, and properly-incentivized pharmacies employing unique adherence
programs may be capable of enhancing adherence above and beyond existing methods.
This thesis explores how traditional chain and independent drugstore pharmacies 1) prioritize
medication adherence; and 2) may benefit from instituting medication adherence programs. The
hypothesis tested was that pharmacies would benefit substantially from instituting adherence
programs. Data from interviews, company financials and industry reports were used to quantify
a value proposition for the drugstore pharmacy. Interviews revealed a strong disconnect in
emphasis placed on medication adherence between pharmacy schools (strong emphasis) versus
pharmacies (moderate to weak emphasis). Within subgroups of pharmacies, chain and
independent drugstore pharmacies placed lower priority on medication adherence compared with
specialty and hospital pharmacies. Data collected for this thesis also indicated that a 25%
increase in medication compliance would increase a community drugstore's annual revenues by
$1.7 M and annual gross profits by over $400,000. These findings indicate that an untapped
opportunity exists for drugstore pharmacies to boost revenue by investing in technologies and
services to increase medication adherence.
Thesis Supervisor: Barbara Bund
Senior Lecturer, MIT Sloan School of Management
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OVERVIEW OF MEDICATION NON-ADHERENCE
Medications represent one of the most important and widely used tools for the treatment and
prevention of disease. Many medications, particularly those prescribed for chronic disease,
require periodic doses on a scheduled basis. For example, a patient with hypertension may be
instructed to take an antihypertensive tablet twice a day, without fail. Health care providers
typically prescribe an allotment of each medication and then rely on the patient to purchase the
medication and use it faithfully. Under these circumstances, the health care provider merely
assumes that the patient will follow his or her instructions. In clinical parlance, the health care
provider is said to assume the patient will demonstrate compliance or adherence to the
prescribed therapy. A widely appreciated flaw in this system is that patients often fail to fill
prescriptions or use them as directed. A particular problem is that patients miss scheduled doses.
The phenomenon of failing to take medications as prescribed is called "noncompliance", or more
recently "nonadherence."
Medication nonadherence is an enormous burden to the world's health care system.
Approximately half of the approximately 3.5 billion annual prescriptions dispensed in the
United States are not taken as prescribed [1]. Poor adherence to medication schedules leads
to a significant worsening of disease, death, and increased health care costs in the U.S. [2-4].
Between 33 and 69 percent of all medication-related hospital admissions (about 10% of all
hospitalizations) in the U.S. are due to poor medication adherence, costing the health care system
$100 billion each year [1]. Most data on medication nonadherence have been collected from
studies performed in the United States, although evidence suggests that these trends apply to the
rest of the world as well.
The problem of medication nonadherence affects patients with all diseases but patients with
chronic asymptomatic illnesses are especially vulnerable. This is because patients do not see an
immediate benefit from taking their medications and in general feel no different day-to-day
whether or not they adhere to their medication regimens. For example, half of patients taking a
"statin" drug (hydroxymethylglutaryl-coenzyme A reductase inhibitor) for asymptomatic
hypercholesterolemia will discontinue their medications entirely within six months of starting
therapy [5]. Similar difficulties in medication adherence can be observed with hypertension. In
addition to these and other chronic asymptomatic illnesses, patients with psychiatric diseases
also have difficulty adhering to medication schedules. For example, nearly two-thirds of patients
with bipolar disorder will not adhere to their prescribed dosing schedules [6]. Similar difficulties
to medication adherence can be observed with children being treated for a variety of illnesses [7].
Given the personal, social, and economic costs of noncompliance, the reasons for this
phenomenon have been studied in detail. An important aspect of medication nonadherence is
that the majority of deviations from prescriptions occur through omissions of doses and delays in
timing of the doses, rather than additions of doses [8]. Many patients exhibit "white-coat
adherence," which is an improvement in medication adherence in the 5 days before and after a
doctor's appointment [9]. In general, six distinct patterns of medication taking behavior have
been observed. One-sixth of patients demonstrate nearly perfect adherence to a medication
schedule; one-sixth have minimal irregularity of dose timing only; one-sixth miss an occasional
daily dose as well as demonstrate irregularity of dose timing; one-sixth take 3-4 "drug holidays"
(days to weeks without taking prescribed medication) per year and, in addition, occasionally
omit doses; one-sixth have drug holidays once every month or more and also frequently omit
doses; and one-sixth take few, if any, of their prescribed doses despite giving the impression to
healthcare providers that they are adhering to their medication schedules [10, 11]. Patients give
one or more of the following reasons when asked why they did not adhere to a particular
medication schedule: forgetfulness (30%), other priorities (16%), decision to omit doses (11%),
lack of information (9%), emotional factors (7%), no reason given (27%) [1]. Race, gender, and
socioeconomic status have not been consistently associated with medication nonadherence.
Clinicians and researchers generally group methods of improving adherence into four categories.
The first category, patient education, involves teaching the patient the benefits of strict
medication adherence and the harms of deviating from the schedule. The second category,
improved dosing schedules, aims to have the patient take multiple medications at the same time
each day, as well as to decrease the frequency of doses, since rates of adherence have been
shown to increase with once daily schedules compared with more frequent dosing schedules
[12]. The third category is to decrease the waiting times for patients to see physicians and also to
pick up their medications from pharmacies. The fourth category is to improve overall
communication between physicians and patients, thereby enhancing the overall relationship and
trust that could lead to increased rates of medication adherence. All of these methods have
shown only limited success in improving the rates of medication adherence. Successful
methods are often highly complex and require intense labor by the payer and health care
professional. Therefore, innovative and practical strategies need to be developed and put to
routine clinical use [1].
OVERVIEW OF THE U.S. PHARMACY INDUSTRY
A patient interacts with many healthcare professionals before receiving medications. The final
and common step in these interactions is that between the patient and pharmacist. An overview
of the U.S. pharmacy industry therefore is essential in analyzing opportunities in enhancing
adherence to medications.
Patients receive their prescribed medicines through a variety of pharmacy types (Fig 1). In
general, the different pharmacies can be categorized as retail pharmacies (traditional chain
drugstores, independent drugstores, mass merchant pharmacies, supermarket pharmacies and
mail-order pharmacies), institutional pharmacies (clinic and hospital pharmacies), and specialty
pharmacies (long-term care or home-health pharmacies).
Retail pharmacies continue to be the most important source of prescriptions for most
Americans. In 2004, retail pharmacies dispensed 75% of all prescriptions and accounted for
94%, or $221 billion, of the revenue generated through all pharmacies [13]. Figure 2 shows the
breakdown of retail prescription drug sales by store type. As evident from this figure, traditional
chain and independent drugstores account for nearly 60% of all retail drug sales.
Figure 1: Retail prescription drug sales by store type
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Figure 2: Retail Pharmacy Prescription Drug Sales by type of Store (2004)
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The United States retail pharmacy industry is a staple of the American culture with a rich history
and rapid evolution throughout the past century. Today's retail pharmacy plays a key role in a
dynamic retail environment. Pharmacies may be located within any store and one way to
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distinguish retail pharmacies is to differentiate drugstores from mail-order pharmacies. The term
"drugstore" can be defined as any store where prescriptions are filled and drugs or other articles
are sold [13]. For the purposes of this thesis, drugstores are further distinguished from Mass
Merchants (e.g. Wal-Mart, Target) and Supermarkets whose main area of business is sales of
non-pharmacy related merchandise. In contrast, drugstore revenues are primarily derived
from in-store pharmacies. For traditional chain drugstores (e.g. CVS, Walgreens), the percent
revenue generated from in-store pharmacies averages 70% [13-15]. For independent drugstores,
pharmacy revenues account for over 90% of total revenues [14].
Given the significant medication adherence opportunity inherent within harnessing the
pharmacist - patient relationship, this thesis further examines chain and independent drugstore
pharmacies.
Drugstore Pharmacies
The importance of the pharmacy to drugstores is underscored by comparing the average per store
sales between traditional chain drugstores, independent drugstores, supermarkets with
pharmacies, and mass merchants with pharmacies. As shown in Figure 3, pharmacy sales
account for nearly 75% of all revenues generated by drugstores. Traditional chain drugstores
generate 68.27% of their sales from the pharmacy, whereas independent drugstores generate
nearly all (94.51%) of their sales from their pharmacies [13]. In contrast, supermarkets and mass
merchants do offer pharmacy services in many of their stores but the pharmacy makes up only a
small fraction of these stores' overall sales.
Figure 3: Average annual total and pharmacy sales per store type (2004)
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The retail pharmacy industry has continued to consolidate over the past decade. Chain
pharmacies, which include traditional chain drugstores as well as supermarket and mass
merchant pharmacies, are increasing their total share of the retail pharmacy industry and now
account for over 2/3 of all retail pharmacies in the United States [16]. There were approximately
55,000 retail pharmacy outlets in the United States in 2004. As evident in Figure 4, the number
of independent drugstores has declined considerably from 1994 (24,862 stores) to 2004 (17,931
stores), a decline of over 30% in 10 years. During the same period, chain drugstores have
continued to buy independent stores and open new stores. In 1994, the number of chain
drugstores was 18,103, and this number has grown to 20,849 within 10 years. Note from the
figure that the number of supermarkets and mass merchants with pharmacies has also grown
considerably. This latter trend is an important competitive threat for traditional drugstores; mass
merchants' business model focuses chiefly on offering "everyday low prices" [17] - including in
their pharmacies - and traditional drugstores cannot compete with mass merchants on price
alone.
Figure 4: Community retail pharmacy outlets by store type (1994 and 2004)
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As a result of continuing market share loss to mass merchants, one important trend in the
drugstore industry continues to be the value placed on convenience: "a drugstore in every
corner" [16]. Every effort is made by large chain drugstores to have a ubiquitous presence.
There is a community pharmacy within 5 miles of nearly every American [13]. Most drugstores
(over 3) are located in metropolitan areas, where the average distance to a retail pharmacy is
1.09 miles [131]. Chain drugstores are more concentrated in urban areas (over 80%) than are
independent pharmacies (65%) [13].
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In 2004, the average individual spent $598 in drugstores, or approximately $50 per month [15].
These per capita sales have increased over 90% from 1994 to 2004 at a rate of 6.7% per year [13,
15, 16]. Gross margins across all drugstores were approximately 25%, which have remained
relatively flat since the early 1990s [15]. Figures 5 compares 2003 per capita sales and gross
margins as a percent of sales across drugstores, grocery stores and discount department stores.
As evident from the Figure, drugstores have respectable sales and gross margins when compared
with other retailers. However, the overall drugstore operating margins remain low (often 6% or
less) compared with many other industries, especially the pharmaceutical industry, which enjoys
margins of approximately 20% [18].
Figure 5: Per Capita Sales and Gross Margin (in dollars / consumer / y) for select types of stores
(2003)
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Prescription drugs are the most important revenue source of drugstores, generating nearly 70% of
all revenue for the industry. However, most stores, especially chain drugstores, rely heavily
on front-end (non-pharmacy) sales to generate profit. The reason is that, although the
pharmacy continues to be an important revenue stream for drugstores, operating margins from
pharmacy sales are exceedingly thin. For an average prescription sale of $64, the pharmacy
retains, on average, only $2 for income [14]. These thin margins are therefore compensated in
part by front-end sales, which generally have higher margins. Indeed, in the drugstore industry,
while the pharmacy is viewed as a traffic driver, the front-end sales are responsible for
generating profit.
Because front-end sales are important for overall drugstore margins, drugstores offer a mix of
merchandise to their customers. The average "basket-size" of customers shopping the front-end
is approximately $22 [19-21]. Consumers purchase a variety of merchandise (Figure 6).
Figure 6. Chain Drugstore Merchandise Mix (2004)
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The pharmacy remains the backbone of the drugstore industry, driving 70% of the revenues in
large chains and 90% of the revenues in independent drugstores [14]. In 2004, traditional chain
drugstores dispensed 1.51 billion prescriptions for a total of $90.6 billion in sales, whereas
independent drugstores dispensed 728 million prescriptions for a total of $40.5 billion in sales
[13].
In 2004, approximately 115,000 pharmacists worked at chain community pharmacies, whereas
only 24,000 pharmacists worked at independent drugstores [13]. California (13,610) and New
York (8,122) had the largest number of pharmacists [13]. Massachusetts had 3000 pharmacist
jobs in 2004 [13]. The median hourly wage of pharmacists was approximately $40 in 2004 [13,
16].
In conclusion, drugstore pharmacies are low-margin, high-volume "traffic-drivers" that
make up the core of a drugstore's business. They operate in an increasingly competitive
environment and are threatened by discount pharmacies within large mass-merchant stores and
supermarkets. In order to stay competitive, drugstore pharmacies have turned to convenience as
their key value proposition for their customers.
Pharmacies and prescription medications
Prescription drugs account for approximately 10% of all healthcare costs in the United States
[22]. The NACDS estimates that the number of prescriptions to be dispensed will increase by
over 20% over the next 4 years to 4.1 billion in 2010 [13]. Prices for prescriptions dispensed at
drugstore pharmacies continue to climb. The average prescription price in 2004 was $63.59,
up from $59.52 in 2003 [13]. There was a large price gap between brand and generic drugs sold
in pharmacies. The average brand drug prescription price was $95.54 in 2004, up 11.7% from
2003 [23]. In contrast, the average generic drug prescription price was $28.71 in 2004, up only
3.5% from 2003 [24]. This 70% gap in prescription prices between brand and generic
prescriptions puts pharmacists at the heart of a heated debate about the substitution of generics
for brand name drugs, a change that has the potential to drive down prescription-related
healthcare costs. A 1996 survey indicates that only 21% of chain drugstore pharmacists and 31%
of independent pharmacists chose "least expensive generic available" as the deciding factor to
stock or administer a drug [25], suggesting that most pharmacists do not prioritize generic
substitution highly. In general, decisions about which drugs to stock are made without engaging
the individual pharmacist. However, as discussed below, pharmacies have a financial incentive
to substitute generics for brand-name drugs and may play a more active role in generic
substitution in the years to come.
For a typical prescription paid for in cash (average 2004 price of $63.59), the manufacturer
receives the majority of the price ($48.65, or 76.5%). The wholesaler receives $2.18 (3.4%) and
the retail pharmacy receives $12.77 (20.1%) [14]. However, the example does not take into
account the dispensing cost of the pharmacy, which is often $7 or more per prescription [26].
With the dispensing cost taken into account, the gross profit margin is less than 10% [26, 27].
The retail pharmacy often obtains a significantly higher gross profit percent for generic
medicines compared with brand prescriptions, due in part to being able to charge a higher
percentage dispensing fee for generics and in part to receiving a higher discount from the
manufacturer for ingredient cost. Table 1 illustrates this point for a typical 30 day, $30 generic
prescription versus a $100 brand prescription. The average wholesale price (AWP) is the base
price used to calculate payer reimbursement to pharmacies.
Table 1: Comparison between generic and brand drug gross margins for retail pharmacies
Generic (% AWP) Brand (% AWP)
Average Wholesale Price (AWP) $30.00 100% $100.00 100%
Collected Dispensing Fee ($) $6.00 20% $5.00 5%
Discount from Payer ($) -$9.00 -30% -$15.00 -15%
Ingredient Cost -$15.00 -50% -$75.00 -75%
Gross Profit I Rx $12.00 40% $15.00 15%
Dispensing Costs -$8.00 -27% -$8.00 -8%
Gross Profit / Rx (after disp. Cost) $4.00 13% $7.00 7%
Sources: First DataBank & Thomson Medical Economics reports, and Deutsche Bank estimates
(November 2004 report on Retailing/Food & Drug Chains)
As evident from this example, the percentage gross profits for generic prescriptions are
considerably greater than for brand medications. Because retail pharmacies can obtain higher
margins from generic versus brand prescriptions, they have a greater incentive to fill generics
and substitute generics for brand prescriptions. In addition to legal and payer mandates
regarding generic substitution, these financial incentives for pharmacies may have accounted for
the brand/generic mix breakdown to move from 60% / 40% in 1994 to nearly 50% / 50% in 2004
(Table 2).
Table 2: Brand/Generic mix of prescription drug prices and dispensing frequency
Average Rx Brand Rx % Brand of Generic Rx
Year price ($) price ($) all Rx Price ($) % generic of all Rx
1994 $28 $37 61.2% $14 38.8%
2004 $64 $96 52.2% $29 47.8%
Sources: IMS HEALTH, NDCHealth, NACDS Economics Department
In sum, drugstore pharmacies receive discounts to substitute generics for brand drugs;
even when not required to substitute, they are increasingly likely to do so in order
maximize their thin margins.
Pharmacy drug suppliers
Pharmacies receive medications either directly from manufacturers or from wholesalers. Only
20% of medications that arrive at pharmacies are shipped directly from pharmaceutical
manufacturers [28]. The rest arrives through both regional and national distributors, which
compete in a $235 B pharmaceutical wholesaling marketplace. Three main distributors take over
70% of the market share in the industry: McKesson, Cardinal Health and AmeriSourceBergen
(Figure 7). These "big three" account for 90% of the national pharmaceutical wholesaling
marketplace [28].
Figure 7: Market share of pharmacy suppliers
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Large distributors contract with multiple chain and independent pharmacies and provide a
myriad of services to automate pharmacy operations (e.g. robotic dispensers), streamline
inventory management, and re-package medications to fit the pharmacy's needs (e.g.,
compliance packaging) [28].
Chain pharmacies provide relatively low margins to distributors but also make up the bulk
of the large distributors' business. For example, CVS pharmacy accounted for 18% of Cardinal
Health's revenue in 2004 [28].
In contrast, distributors extract high margins from independent pharmacies, which do not
have sufficient purchasing leverage to negotiate aggressively with distributors. Furthermore,
many independent pharmacies use other value-added services that are offered by distributors,
such as automation tools and inventory management systems [28].
DRUGSTORE PHARMACIES AND MEDICATION ADHERENCE
Traditional chain and independent drugstore pharmacies directly interact with millions of
patients each year in order to hand-deliver prescriptions. The pharmacist might be able to help
improve patients' compliance. Therefore, in an effort to evaluate the attractiveness of
opportunities to enhance medication adherence, interviews with a spectrum of pharmacists were
conducted to better understand the priority that pharmacists place on medication adherence.
Methodology
The HealthNet Pharmacy Directory [29] was used to identify all Massachusetts Pharmacies and
45 pharmacies in the Greater Boston Metropolitan area were contacted by phone with interview
requests. In addition, business colleagues and interviewees were asked to identify individuals
with a background or experience in the pharmacy industry. Seventeen structured interviews,
either by phone or in person, were conducted between February 15, 2006 and April 15, 2006
with pharmacists representing a diverse number of specialties. The length of the interviews
ranged between 15 minutes and 2 hours. Most interviews were conducted in person at the
pharmacy in order to observe store layout, dynamics and overall environment that may impact
medication adherence programs. The locations included independent, chain, specialty, hospital,
university campus and long-term care pharmacies (i.e., those pharmacies servicing nursing
homes, chronic mental care facilities, and other institutions caring for individuals on a long-term
basis). When relevant, web searches and industry reports confirming or rejecting assertions
made by the interviewees are also included and referenced.
Table 3: Interviews conducted for this thesis
Title Work environment Type Lengt
h
Pharmacist Independent In -person 1 h
Pharmacist and Owner Independent In-person 1 h
Pharmacist and Owner Independent In-person 15 min
Pharmacy Manager Specialty Pharmacy In-person 1.5 h
Pharmacist Hospital Pharmacy Phone 30 min
Pharmacist Hospital Pharmacy In-person 15 min
Pharm. manager/MBA Chain In-person 2 h
Pharmacist Former Chair, Mass. Pharmacy Association In-person 30 min
Pharmacist & Manager Chain Phone 10 min
Pharmacist Specialty Pharmacy and Pharma. Industry Phone 1.5 h
Pharmacist School of Pharmacy/Residency director Phone 45 min
Pharmacist/former owner Director of the Board of Pharmacy In-person 1 h
Pharmacy Owner Independent Phone 45 min
Pharmacist Independent In-person I h
Pharmacy manager Specialty In-person 15 min
Pharmacist, Director of University Campus In-person I h
Pharmacy
Pharmacist Chain Phone 15 min
General Work Environment
It was found that pharmacists, pharmacy managers and store owners have little control over
their daily schedules and in general work non-stop throughout the day in an effort to fill
prescriptions on time. Very little down-time was observed. With the exception of a meeting
with one independent pharmacy owner, all interviews were scheduled during off hours. Most
pharmacists reported being frustrated with the lack of additional flexibility in their work
schedules but did note that their week usually did not exceed 50 h of work. The shortage of
pharmacists was the main reason given for the busy work schedules. Nearly half of the
pharmacists reported that they were at least one "pharmacist short"; this was the most common
reason for declining an interview request. Few pharmacists had time to take lunch breaks.
Pharmacists were observed to work and maneuver around a relatively small space.
Relatively little space was dedicated to dispensing and filling medications, whereas the majority
of space was taken up by storage areas for medications. Employees were also frustrated by the
lack of space, especially during peak hours when multiple pharmacists and pharmacy technicians
were present within the same common space. Few or no chairs were found in the work spaces.
The one exception to the crowded feel was found at a long-term care pharmacy, which enjoyed
large tables and ample walking room. The owners of this long-term pharmacy noted that its
large space was an attractant for freshly-minted pharmacists who had the option of signing up
with larger chains for more lucrative salaries but a less "user-friendly work environment".
Despite the hectic schedule and cramped work environments, most pharmacists tended to be
relatively happy with their career decisions and noted that the high demand for pharmacists
had accounted for excellent salaries. A veteran pharmacist and store owner noted that "some of
the large chains are offering new pharmacists a starting salary of $110,000 plus a new BMW".
This comment was confirmed by conversations with young pharmacists, who reported overall
that they had little to no difficulty in landing jobs, especially at chain drugstores. However, they
did note that the downside was to work a "more-or-less monotonous day" filling prescriptions
and calling doctor's offices to confirm orders.
Key business drivers
Pharmacy owners and managers were asked about how the pharmacy aims to extract more value
from customers. All interviewees initially responded that the primary goal of the pharmacy was
to educate the patient but on further questioning listed several important value drivers:
* Increasing store traffic - Both chain and independent drugstores valued increased
store traffic but chain pharmacies placed considerably more emphasis on methods to
increase store traffic. For example, large chain drugstores placed weekly promotional
advertisements distributed by newspaper, radio, television, front-store flyers, website,
and email to the general public. In contrast, few or no promotions were advertised by
independent pharmacies. One reason for this difference, given by owners and
managers of independent pharmacies, was that independent pharmacies often lacked
the resources and cash necessary for promotions. Instead, as explained below,
independent pharmacies focused on harnessing their relationships with their
communities in order to increase store traffic. Both chains and independents
acknowledged that in large chains, the primary role of the pharmacy was as a low-
margin "traffic-driver" so that customers who entered the store had an opportunity to
shop the higher-margin front-end of the store. In contrast, independent pharmacies
relied primarily on their pharmacies for both margin and traffic.
* Increasing spend per customer - Independent pharmacies placed little priority on
increasing spend per customer per visit. In contrast, chain pharmacies used
considerable resources to enhance spend per customer. Chains often used the
pharmacy as a traffic-driver. The in-store pharmacy was placed strategically at the
back-end of the store in order to give each patient the maximum "front-store
exposure" on his/her way to the pharmacy. The large chains invested heavily in
research to better understand shopping habits per customer. For example, Figure 8
shows the frequency of customers visiting different parts of one traditional chain
drugstore. As evident from this analysis, it is possible for chain drugstores to display
high-margin items strategically alongside those that shoppers frequently buy [30].
Increasing spend per customer was a central theme adopted by the National
Association of Chain Drug Stores (NACDS) in its 2002 "Selling One More Thing"
report and campaign [31], which instructs drugstores how best to generate revenue by
encouraging shoppers to buy one more thing before they leave. For example, the
report showed that placing candies by the pharmacy counter increased candy sales by
30%. It encouraged chain stores to use the traffic-driving pharmacy in order to sell
just "one more thing" [31]. Independent drugstore owners and managers noted that
their stores did not benefit from such strategies, nor did they think about ways to
increase spend per customer. Owners of independent pharmacies noted that one
reason was that, unlike large chain drugstores, the front-store of independent
pharmacies was not a primary source of revenue. Less than 10% of the entire revenue
for the independent drugstore came from front-end merchandise. Respondents from
independent pharmacies said there was not a large difference in margin between
front-end sales and pharmacy sales for their stores.
Figure 8: An example of a drugstore shopping frequency analysis
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Source: Storeboard Media, Sorensen Associates Pathtracker Research
* Retaining existing customers - Independent pharmacies placed considerable
emphasis on retaining existing customers. Independents felt that their primary
competitive advantage was their ability to harness their existing relationship with
their communities and "being part of the community". Several independents
contributed small prizes to raffles run by high school sports teams, Little League, and
...•J..:•.,..•El
community churches. They also placed ads in community newspapers and the local
high school yearbook and were overall more involved in community activities than
their chain counterparts. One owner was a part of the local Rotary Club in part for
this reason. Often, pharmacists and store owners knew many of their customers by
their name. In one independent store, the store owner struck up conversations with
several of his customers. He later noted that he personally valued these relationships
and felt that his customers felt the same way. Respondents in chain drugstores also
said it was important to retain their customers but they approached doing so using
"loyalty cards", such as the ExtraCare card used by CVS pharmacies [32]. Customers
who used an ExtraCare card when making a purchase received an immediate discount
on some items purchased at the store and also received additional perks when
shopping at the drugstore. Other large chains implemented similar loyalty programs.
Promotional advertisements by chains also emphasized that they place priority on the
patient - pharmacist relationship. However, interviews conducted with both chain
drugstore pharmacists and independent drugstore pharmacists with experience
working at chains revealed that in reality chains placed relatively little emphasis on
harnessing the pharmacist - customer relationship. One common reason given for
this situation was that chain pharmacies were often "too busy filling prescriptions"
compared with independent stores. In addition, several pharmacy managers and
owners pointed out that the financial incentives for a chain pharmacist were not
structured in a way to promote the pharmacist - patient relationship. Chain store
managers and owners were incentivized by the number of prescriptions filled per day
and no incentive structure existed that rewarded a conversation with a patient. One
chain pharmacist lamented that the pharmacy profession has moved away from being
a "guide and healer" harnessing fulfilling interactions with the patient in order to
dispense accurately, to being a "mechanic" filling a high number of prescriptions
throughout the day.
In conclusion, chain pharmacies placed more emphasis on using their pharmacies to drive
store traffic, whereas independent pharmacies prioritized building relationships with their
patients in order to retain loyal customers. Chain pharmacies also placed a high priority on
increasing cross-shopping to increase spend per customer visit.
Attitude towards Medication Adherence
All pharmacists, pharmacy managers and owners were familiar with the concept of medication
adherence. However, there were vastly differing views on its importance. A director of
education and residency at a pharmacy college placed a very high value on the importance of
medication adherence. Indeed, this person said that promoting medication adherence should be
"one of the top priorities for any pharmacist", adding that the pharmacy school dedicated a
significant portion of its curriculum to teaching pharmacists-in-training about medication
adherence. Pharmacy students are taught that improving the pharmacist-patient relationship is a
proven way to increase medication adherence rates and they are encouraged to make every effort
possible to spend the "extra few minutes" counseling the patients to take their medicines on time.
However, when this interviewee was asked if he thought his graduating students did so, he
admitted that they probably did not.
In fact, interviews with practicing pharmacists and pharmacy managers revealed that most
interviewees did not believe that medication non-adherence was a significant problem.
Among independent drugstore interviewees, the majority of those who were interviewed
indicated that, on average, patients were "only 3-4 days late" in filling their prescription. More
importantly, the interviewees indicated that "this was not a big problem" and that improving
medication adherence would not impact their bottom-line significantly. They added that if one
of their patients was more than 1-2 weeks late, then this lateness would trigger a flag on the
computer and prompt them to call the patient to remind him or her. Chain pharmacy employees
also indicated that they did not often think about medication non-adherence but suggested that, in
their experience, it was "less of a problem than what we were taught". Most employees
identified specific groups of patients who were more likely to be non-compliant, including HIV-
infected patients and chronic disease patients such as those with diabetes and hypertension.
Most employees felt comfortable with their abilities to identify non-compliant patients, either by
refill records or., in the case of independent pharmacists, because they "know the patient".
Medication Adherence versus Medication Dispensing Errors
While patient adherence to medications received a low to moderate priority for independent and
chain drugstore pharmacies, medication dispensing errors were highly prioritized. The "error
rate" was defined as the frequency of dispensing a wrong medication, schedule or dosage. A
variety of systems were adopted by pharmacies in order to reduce the error rate. Automation
was given a top priority by chain pharmacies, in part because these systems were shown not only
to reduce error rates but also to increase efficiency and prescription turnover rates. Even
pharmacies with very low rates of medication errors were interested in further reducing their
error rates. One reason for this interest was that dispensing errors could lead to serious health
consequences for the patient, especially if the wrong medicine or dosage was dispensed. It was
noted that many such incidents were publicized widely and even minor errors could be disastrous
to the reputation of the pharmacy. In fact, when the topic of the thesis was introduced, several
pharmacists and pharmacy managers assumed that it had to do with medication error rates rather
than medication adherence. A Director of the Pharmacy Board even classified medication non-
adherence as a subtype of medication dispensing error.
Medication labeling for increased patient compliance
Clear labeling on prescription bottles potentially may increase patient compliance. Large-font,
easy-to-read labels containing prescription name, dose and schedule theoretically could increase
medication compliance rates. Consequently, pharmacy employees, managers and owners were
interviewed on their medication labeling practices.
No standardized labeling system was found amongst the pharmacies visited and employees
interviewed. Some pharmacists chose to provide as much information as possible on the label
and others chose to print very little information. Font size also varied widely, with some
pharmacies printing in <8 point and others printing >12 point. Interviews with the State Board
indicated that no specific regulation existed for labels that were adhered to the outside surface of
the bottle. Most everyone was aware of a new labeling system designed by Target ("ClearRx
Prescription System"), which uses large, boldfaced fonts in labeling a colorful prescription
bottle. However, few pharmacists and pharmacy managers were impressed with this new
labeling system and they responded that their stores would choose to keep the current, traditional
system. When asked if improvements in labeling could improve patient adherence, most
interviewees responded that they did not think that it would make a significant impact.
The Journey of the pill from Manufacturer to Patient
Pharmacies were asked to walk through what happens from the time a drug is manufactured to
the time it reaches the patient. The following sequence was reported by most of those
interviewed (Figure 9):
Figure 9: The Journey of the Pill from Manufacturer to the Patient
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1. Drug is manufactured
2. Drug is bottled - interviewees categorized medications into two types: those received in
bulk and those pre-packaged in single monthly prescriptions. Bulk prescriptions were
bottled in containers of 100, 500 or more pills. Pre-packaged prescriptions usually were
placed in containers of 30 (for once a day formulations) or 60 (for twice a day
formulations). A small but growing number of drugs were blister-packaged in monthly
prescriptions at the pharmaceutical company or wholesaler.
3. Drug is distributed - interviewees indicated that most manufacturers used distributors in
order to reach a large number of pharmacies nationwide.
4. Drug arrives at the pharmacy - most pharmacies had contracts with several distribution
companies and received their shipments on a rolling basis. Pharmacists felt comfortable
in their ability to receive medications on an "as-needed" basis provided that there was at
least a 1-2 day lead-time. Medications arrived either in bulk (100+ pills per large bottle)
or in individual monthly or three-monthly bottles.
5. Drug is stored - arriving medications were put on shelves for later repackaging or
dispensing. Shelf space was found to be limited for almost all pharmacies visited.
Pharmacies preferred receiving their most frequently dispensed medications in large
bottles which they found saved shelf space. Both pharmacy technicians and pharmacists
were involved in shelving prescription bottles. Both chain and independent pharmacies
used a coding system that enabled the pharmacist to quickly identify the prescriptions.
For example, one independent pharmacy used a sophisticated color labeling system on its
shelves in order to differentiate medications by how in-demand the drugs were, to ensure
that each medication was adequately stocked. Price (to pharmacy) of each prescription
was clearly visible on the shelf label of several pharmacies. Larger pharmacies tended to
use an automated reader in order to scan the information provided on the shelf label.
This information was then exported directly onto the computer and label in order to
facilitate dispensing and further automated the dispensing process to reduce errors.
6. Drug is repackaged - if the drug arrived in bulk, then the pills would be counted and
placed in smaller containers before being delivered to the patient. Most large
pharmacies, usually operating as part of chains, used automated pill-counters in order to
quickly count and load large numbers of prescriptions for their most in-demand drugs.
Most independent pharmacies used pharmacy technicians and pharmacists to count and
repackage medications. Pharmacies preferred UV-resistant orange "vials" as the final
bottles to be dispensed to patients and they kept hundreds of those bottles them stored in
various places. Respondents seemed to prefer maintaining stocking space of these orange
vials over maintaining stocking space for similarly-sized monthly (or three-monthly) drug
bottles sent directly from the manufacturer. If the drug arrived as a single monthly
prescription from the manufacturer, then the pharmacist (or pharmacy technician) would
skip the counting and repackaging step and simply put a label on the bottle and dispense
it to the patient.
7. Drug bottle is labeled - although automated labelers do exist and are used by some
pharmacies, the pharmacies visited for this thesis labeled bottles by hand. Labels were
printed by laserjet printers and put directly onto the surface of the bottle. Most labels
occupied less than half the available surface area of the bottle. Some pharmacies used
commercially available labeling software, whereas others modified word processor files
for labels.
8. Bottle is held for patient - in some instances, prescriptions were dispensed immediately
for patients present in the waiting area. Pharmacists or technicians usually called waiting
patients by name to complete the transactions. In many instances, however, labeled
bottles containing medications were placed in small paper bags and held for patients near
the pharmacy counter. These bags were also labeled with the patient's name and were
often sorted alphabetically for easy access by the pharmacist.
9. Prescription is given to the patient - the Massachusetts Board of Pharmacy required
that only registered pharmacists (R.Ph.) physically handed the prescription to patients.
However, it was noted that pharmacy technicians often performed this task instead of
registered pharmacists. In addition, pharmacists are strongly encouraged by the Board to
instruct their patients verbally on proper dosing, scheduling, indication and side-effects of
the medication. Some pharmacists did spend a considerable amount of time counseling
their patients in this manner. However, it was noted that a few pharmacists (or pharmacy
technicians) sometimes spent little time on this task, even for new customers. The
study's small sample size prevented accurate comparisons of the length and quality of
patient counseling between chain and independent pharmacies.
10. Completion of transaction - the patient verified his or her insurance information with
the pharmacist (or pharmacy technician) and handed the pharmacist a co-pay in order to
complete the transaction. Co-pays varied widely between brand and generic prescriptions
and between health insurance carriers but usually ranged from $5 to $20 per prescription.
For the most part, pharmacists and pharmacy technicians preferred dispensing 30- or 90-day
prescriptions that arrived pre-packaged from the manufacturer. "It's easier to just grab the bottle
from the shelf and slap a label on it", said one pharmacist, "instead of having to count the pills
and put them into another vial first". However, the fraction of "ready-to-dispense" prescriptions
was often less than 25% of the total in-store inventory. Pharmacy owners and managers
preferred to order in bulk when possible. Interviewees stated two advantages of ordering in bulk
for commonly-used medications. The first was that the pharmacy could potentially (but not
always) receive a small discount on the medication for ordering in bulk. The second was that "a
few large bottles occupy less shelf space than a lot of small bottles" and bulk orders were viewed
as conserving precious shelf space. In general, popular antihypertensives and cholesterol
lowering medications were bought and stored in bulk, whereas more expensive and uncommon
medications such as antiretroviral medicines for HIV and immunosuppressive drugs for
transplant were bought and stored in 30-day prescriptions.
In sum, most medications arrived at the pharmacy in bulk and were then re-packaged
manually or by automated counters into smaller vials before being dispensed to patients.
Most pharmacists received medications from national distributors rather than directly from
manufacturers.
Blister-packaging for increased patient compliance
Blister packages are cards in which pills reside in small plastic bubbles backed with foil. In order
to retrieve the pill, a patient pushes on the bubble to extrude the pill through the foil. In addition,
the card often has room to print important information about the proper use of the medication.
Pharmacies had the option of either blister-packaging medications themselves, ordering pre-
blister packaged medications, or not using blister packaging for their medications. While some
short term medications were found to be pre-packaged in blister packs (e.g., Z-pak, or
azithromycin, from Pfizer), most chronic medications were not blister packaged. One exception
to this rule was birth-control medications.
Blister packaging is an accepted and widely used method of dispensing medications worldwide.
In fact, European pharmacies routinely dispense blister packs to their patients. However, in the
United States, blister packaging is relatively uncommon, in part because compliance with U.S.
Federal laws required that prescription drugs intended for household use are shipped from the
manufacturer (or distributor) in formats that are both 'child-resistant' and 'senior-friendly' [33].
The basis for this law is the Poison Prevention Packaging Act of 1970 (PPPA), which requires
rigorous testing to ensure that medication containers meet these dual criteria. Importantly, the
law also specifies that manufacturers do not have to use child-resistant/senior-friendly formats
for packages that are not intended for household use [33]. This law explains why the
overwhelming majority of prescriptions in the United States are shipped in bulk rather
than bottles of 30 pills or blister packs.
Only a few pharmacies were found to carry blister-packaging capabilities. One pharmacy
that specialized in long-term care for servicing hospice and nursing homes utilized blister-
packaging heavily. This service was billed an additional packaging fee, usually a $1 to $5 /
weekly package. The pharmacy manager felt that this was a good source of additional revenue
that also increased patient adherence to medication. However, he noted that this service was
only in demand from certain nursing homes and long-term care facilities servicing mentally ill
patients and that users of the service were often trained staff rather than the patients. He
therefore indicated that most community pharmacies would probably have little demand for such
a service. Conversations with community pharmacy employees confirmed his suspicion - in
fact, few pharmacies offered a blister packaging service. Those that did offer the service
indicated that revenues generated from blister packaging made up a small fraction of the overall
revenue generated from the pharmacy.
Most interviewees indicated that blister-packaging more medications would probably increase
medication adherence rates. Some were aware of a study from Ohio State University's Philip
Schneider and colleagues [34], which showed that re-packaging a common antihypertensive
medication (lisinopril) increased medication adherence by 14% over a span of 2 years. However,
ftr the most part and despite the increased compliance that may result, interviewees did not
believe that the added cost of repackaging translated into a favorable profit margin for the
pharmacy. "Pharmacies are incentivized by how many prescriptions they dispense and, for the
chains, how much 'front-end' sales they bring", stated one chain drugstore interviewee. "Why
would they be motivated to spend extra cash on compliance packaging?"
Paying for increased medication adherence
Interviewees were asked, "if there was a way to increase medication adherence rates to 100% for
all of your customers, would you pay for it, and how much?" All interviewees responded that
the pharmacy should not pay for increasing medication adherence. When asked, "who should
pay for it?", the majority of respondents answered that pharmaceutical companies would have
the most to gain from increasing adherence. When asked "why?", one of these interviewees
responded that "increased compliance means increased consumption", implying that the
pharmaceutical manufacturers would have an opportunity to sell many more medications by
increasing adherence rates. Some interviewees indicated that the insurance company should take
on the burden of paying for programs to increase medication adherence rates. When asked if
the pharmacy should pay any part of the cost to implement medication adherence
programs, the vast majority of pharmacy owners and managers responded that they did
not think so. A primary reason given was the difference in operating margins between the
pharmaceutical and pharmacy industries, as shown in Figure 10. The 20% operating margins
seen regularly in the pharmaceutical industry were looked upon enviously by both chains (4-6%
margins) and independents (<5% margins).
Figure 10: Operating profit margins for leading pharmaceutical companies
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Conclusions from interviews
Although pharmacists-in-training and pharmacy schools placed considerable emphasis on
medication adherence, the retail drugstore pharmacy industry did not highly prioritize
medication adherence. Independent pharmacies placed more emphasis on increasing adherence
through building relationships with patients, whereas chain pharmacies placed more emphasis on
increasing adherence through investing more heavily in automation to reduce overall error rates.
All pharmacists and pharmacy managers prioritized reduction of medication dispensing error
rates more than increasing medication adherence rates.
r
Caveats of the interview-based analysis: Data collected from these interviews have several
shortcomings. First, the number of individuals interviewed for this study was small, which could
introduce an opinion bias to the study. Second, the sample of individuals agreeing to an
interview may have had inherently similar opinions about medication adherence compared with
those that declined a request for an interview, although there is no particular reason to believe
that this may have been the case. Third, interviewees were not all selected at random; several
interviewees were referred by other interviewees, which could have introduced an additional bias
of opinion. Fourth, while the number of owners, managers and executives interviewed from
independent drugstores was respectable, only one manager (and no current owners) of a chain
pharmacy were interviewed. In addition, no senior executives at the large chain drugstores (e.g.
CVS, Walgreens) were interviewed due to the difficulty in scheduling appointments with these
individuals. Finally, interviews were conducted within and around the Greater Boston area and
may have introduced a location-bias to the data. For these reasons, data collected from all
subjects should be interpreted with caution and may not necessarily apply to the industry as a
whole.
WHAT INCREASING MEDICATION ADHERENCE WOULD
MEAN TO PHARMACIES: A QUANTIFIED VALUE
PROPOSITION
The value of increased medication adherence for drugstores was calculated by quantifying the
impact that enhanced patient compliance may have on prescription sales and front-store sales.
Both prescription sales and front-store sales were named as important considerations driving
growth for drugstore pharmacies. However, the higher-margin front-store sales were
considerably more important for chains (30%+ store revenues) compared with independents
(<10% of store revenues). Two models were constructed in order to assess the impact of
increased medication adherence on drugstore sales and gross profits (Tables 4 and 5).
For constructing the chain drugstore model, the following were assumed:
1. Adherence to medications could be increased by 25%;
2. The average number of prescriptions filled by all customers frequenting a given
pharmacy was 10 / customer [13];
3. The average prescription price was $64 [13]. This number is based on data provided by
the NACDS for 2004;
4. The gross margin for incremental pharmacy sales was 23% [24, 26];
5. The average customer visited a chain drugstore 15 times / year [20, 21];
6. The "basket size" per trip for non-prescription drug items ("front-store" items) was $15 /
trip [20, 21]. That is, the average customer visiting a drugstore spent $15 per trip on non-
prescription related items;
7. The fraction of pharmacy sales compared with overall store sales ranged between 60%
and 800/% [13];
8. The number of prescriptions filled per day was 300 [13, 15, 16, 18, 26];
9. The number of stores in a given large chain drugstore was 2500 [13, 32];
10. The number of chain drugstores in the industry was 20,000 [13];
11. For the purposes of this model, increased medication adherence was defined solely as
increased prescriptions dispensed by the pharmacy. In other words, the impact of
medication adherence on store loyalty, increased store traffic unrelated to pharmacy
visits, new customers, and other variables were not included in this model.
Based on these assumptions, the model shown in Table 4 indicates that if an average chain
drugstore could increase medication adherence by 25%, it could extract an additional $160 /
customer / year from pharmacy sales and an additional $4.95 / customer / year from front-end
sales. These increases translate into an additional $36.80 / customer / year in gross profit from
pharmacy sales and an additional $1.58 / customer/ year in gross profit from front-end sales.
The total increase in revenue would be $164.95 (19% increase), with increased gross profit of
$38.38 per customer per year (17.5% increase). Over the course of a year, a single store can
generate an additional $1.78 M in revenue and a large chain with 2500 stores would generate
an additional $4.4 billion in revenue.
Table 4: The impact of a 25% increase in medication adherence to chain drugstores
Current Increased adherence Target % Increase
Annual Pharmacy Sales / Customer
Prescriptions
Average Rx Price
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A similar analysis was conducted for independent drugstores, with the assumptions revised to
reflect the lower dependence on front-end sales (Table 5). Based on this analysis, it was found
that if an average independent drugstore could increase medication adherence by 25%, it could
extract an additional $160 / customer / year from pharmacy sales and an additional $1.65 /
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customer / year from front-end sales. These increases translate into an additional $36.80 /
customer / year in gross profit from pharmacy sales and an additional $0.53 / customer/ year
in gross profit from front-end sales. The total increase in revenue would be $161.65 (23%
increase), with increased gross profit of $37.33 per customer per year (23% increase). Over the
course of a year, a single store can generate an additional $1.74 M in revenue.
Table 5: The impact of a 25% increase in medication adherence to independent drugstores
Target: 25%
Current Increased adherence Target % Increase
Annual Pharmacy Sales / Customer
Prescriptions
Average Rx Price
Revenue
10
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$64.00
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Annual Front-end Sales / Customer
Total trips / y
Non-Rx Basket Size / trip
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Revenue
10 2.5
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Annual Combined Sales / Customer
Store revenue (%) from Pharmacy
Revenue
Gross Profit
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S$16'3).20 $371.33
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# scripts filled / day
# scripts filled/year
# customers /year
Single Store Sales
Single Store Gross Profit
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Industry-wide Gross Profit
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Several conclusions can be drawn from this analysis. For one, the increase in sales and gross
profits could be substantial in an industry when the operating profits are often so thin (<5-6%).
Indeed, any store that adopts measures to increase medication adherence could enjoy a
significant profit increase based on increased pharmacy prescriptions alone. Second, it is evident
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from this analysis that the impact of increased medication adherence on additional front-end
revenue would be small. The majority of sales gain comes from prescription sales. On first
glance, the lower-margin pharmacy is seen by the industry as a "traffic-driver" instead of a profit
center. When this analysis was first begun, it was expected that the gains in profits resulting
from increased medication adherence would come chiefly from the higher-margin front-end sales
due to the resultant increased store traffic. However, analysis of the current model indicates that
increasing medication adherence would have a significantly larger impact on pharmacy revenues
(and profits) compared with sales of non-prescription items. Finally, these data suggest that
both chain and independent drugstores could benefit significantly from instituting
medication adherence programs.
CONCLUSIONS
Non-adherence to medications is a major healthcare problem. The drugstore pharmacy, which
physically delivers the prescription medication to the hands of the patient, is at the epicenter of
the non-adherence problem. Pharmacies present a unique and potentially very powerful
opportunity to increase medication adherence. Indeed, data provided in this thesis lends
credence to the notion that increasing medication adherence would have a positive impact on
pharmacy sales. Unfortunately, interviews with pharmacists, owners, managers and regulators in
the pharmacy industry indicate that, while a significant emphasis on medication adherence is
given at pharmacy training programs, the community pharmacy puts a relatively low
priority on increasing medication adherence. This disconnect between pharmacy training
programs and community pharmacies results in large part from the day-to-day schedules that
plague most chain and independent pharmacies: the busy workday, high demand for (and low
supply of) registered pharmacists, and lack of appropriate financial incentives that could properly
motivate increased time spent on patient counseling or other patient compliance services.
Examining the journey of a pill from manufacturer to patient may give clues to the most effective
ways that a pharmacy can increase medication adherence rates (Fig. 11). One way that
pharmacies may increase medication adherence is to use bottles specifically designed to
remind or motivate patients to take their pills (#1). For example, the bottles could be
designed to capture and dispense one pill at a time or could have a built-in alarm to remind the
patient at appropriate times. Several reminder devices are commercially available but in general
they are marketed directly to the consumer and require the patient to first remove the medication
from its original bottle and place it in the pill organizer. In addition, only a few pharmacies are
experimenting with innovative bottle designs specifically designed to improve medication
adherence (e.g. Target's ClearRx Prescription System), in part because cash-strapped pharmacies
are not incentivized to invest in expensive, unproven technologies. Therefore, any pharmacy-
oriented solution that uses innovative bottles must be 1) inexpensive; and 2) proven to increase
adherence by a reasonable amount (e.g., >10-15%).
Figure 11: Possible Pharmacy interventions to enhance medication adherence rates
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A second way that pharmacies could increase medication adherence rates is to dispense more
medicines in blister packs (#2). Experimental evidence suggests that blister, or "single unit",
packaging could increase medication adherence rates [35-37] and pharmacies could potentially
boost patient compliance by dispensing more blister-packaged medicines. In addition to
requesting more blister-packaged medications from manufacturers (or distributors), pharmacies
may also blister package medications themselves. Blister packaging increases dispensing time
but only by about 10 seconds; during research for this thesis, it was observed that a pharmacist
could dispense 30 pills into a blister pack in approximately 20-25 seconds, as opposed to about
10-15 seconds for dispensing into a traditional orange vial. Blister packaging at pharmacies does
require a capital investment, however, and in general only specialty or long-term care
pharmacies can justify the added cost for blister packaging. Large-scale randomized trials that
demonstrate a clear adherence benefit for blister packages over traditional bottles will probably
be necessary for traditional drugstore pharmacies to change to blister packs.
A third way that pharmacies could increase adherence is to improve labeling (#3). Research for
this thesis revealed that a standardized labeling method does not exist amongst pharmacies.
Some labels are so cramped with information that the patient might feel overwhelmed and unable
to read the drug name, dose or schedule, and therefore may not adhere to the prescription.
Bottles were found to have ample free space remaining after labeling; if this additional space was
used to increase font size, then it might be possible to avoid confusion for most patients. In
addition, since the majority of medication users are elderly individuals with a variety of visual
problems (e.g., presbyopia and age-related macular degeneration), large-font labeling could be
expected to enhance adherence rates. Finally, since labeling is not strictly regulated by the
pharmacy Board, it is possible to use colored fonts to make the labels more "catchy". This
change could serve as an additional reminder or motivator for the patient to adhere to their
medications. In addition, label changes are not time consuming and one-time modifications
could be instituted throughout the pharmacy to enhance patient adherence rates. However,
printing labels in color fonts would require color printers, which may be an excessive cost to
most pharmacies competing in the low-margin industry.
Finally, pharmacists can enhance medication adherence simply by counseling patients longer
on the importance of compliance to the prescribed regimen (#4). A large body of evidence
strongly supports the notion that direct pharmacist counseling can increase medication adherence
rates, reduce complications from chronic diseases, and reduce hospitalizations [38-45].
Unfortunately, pharmacies operate within an intensely pressured landscape that demands a high
volume of dispensed prescriptions per day; in this regard, pharmacies are incentivized to spend
less, not more, time with their patients. Any additional time that the pharmacist spends with the
patient translates into less time dispensing medication, which could lead to longer waiting times
and less overall daily volume of dispensed prescriptions. If pharmacies are to institute increased
time counseling patients, then they must be incentivized to do so. Several options exist. One
possibility is that pharmacies could receive government subsidies if they are able to demonstrate
proof of increased time counseling. Proof could come in the form of the patient's signature on a
"patient compliance form", which indicates that the pharmacist has discussed at length (e.g., at
least 5 minutes) the consequences of non-compliance to a medication regimen. Pharmacies that
generate 100 such signatures per day, for example, would be eligible for a sizeable medication
compliance subsidy. This is but one of many possibilities that could be explored to incentivize
pharmacies to counsel patients on medication adherence.
Any solution that will have a significant impact on patient adherence to medications must
consider these very real difficulties that pharmacy employees deal with on a routine basis. Any
product or service that aims to increase medication adherence must be an inexpensive,
easy-to-implement, and minimally-time-consuming solution. Furthermore, the solution must
either make the pharmacist's busy schedule more streamlined or at the very least not add
additional burden to his or her workday. An innovative solution with these attributes could have
a significant impact on patients, healthcare providers, and also on both the top- and bottom-line
of the community drugstore pharmacy.
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